ATH 33.3% 1.2¢ alterity therapeutics limited

Funding good until well past Phase IIa results, proven results...

  1. 11,522 Posts.
    Funding good until well past Phase IIa results, proven results on using substituted 8-quinolinols for treatment of AD, exceptional metal chelation agents, PBT2 improvement on PBT1, then onto the possibility of treating Parkinsons and others.

    Looking to top up, good luck.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
1.2¢
Change
-0.006(33.3%)
Mkt cap ! $63.84M
Open High Low Value Volume
1.3¢ 1.4¢ 1.1¢ $1.532M 123.5M

Buyers (Bids)

No. Vol. Price($)
27 22832937 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 8547260 6
View Market Depth
Last trade - 16.10pm 31/01/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.